Abbott expands low cost Kaletra.
D003906:Developing Countries; D004345:Drug Industry; D015658:HIV Infections / Q000188:drug therapy* / Q000191:economics*; D017320:HIV Protease Inhibitors / Q000191:economics* / Q000600:supply & distribution; D006801:Humans; D061466:Lopinavir; D017149:Private Sector; D011744:Pyrimidinones / Q000191:economics* / Q000600:supply & distribution; D019438:Ritonavir / Q000191:economics* / Q000600:supply & distribution
D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir